A hallucination-free revolution in psychiatry is at hand: The mysterious shield of magic mushrooms in the brain has been solved

The world of modern medicine and neurobiology has reached a game-changing new stage in the treatment of psychiatric disorders such as depression, Post-Traumatic Stress Disorder (PTSD) and severe anxiety. The research, conducted by researchers at the University of California (UC Santa Cruz) and published in the world-famous science journal Nature Neuroscience, revealed the power of psychedelic substances to restructure the brain.

Focusing on the psilocybin compound found naturally in species known as "magic mushrooms", scientists observed for the first time in living tissues how the molecule quickly rearranges the communication and connections between brain cells.

MATURES SYNAPSE CONNECTIONS IN THE BRAIN IN 24 HOURS

In experiments conducted on live mouse neurons using advanced two-photon microscopy technology, it was found that new neural connections (dendritic spines) rapidly sprout in the cerebral cortex, the brain's center of perception, decision-making and emotion regulation, just 24 hours after psilocybin administration.

Psilocybin not only triggered "neurplasticity," the brain's ability to renew and adapt itself; It also enabled the newly established fragile connections to transform into permanent, strong and mature "mushroom"-shaped synapses. This cellular change proved that even a single dose of the drug could permanently repair neural circuits disrupted in depression.

IT WORKS COMPLETELY DIFFERENTLY IN STRESSED AND HEALTHY BRAINS

One of the most striking findings of the study was that the drug produced different cellular responses in healthy and chronically stressed brains. In mice under chronic stress, which mimics depression in humans, psilocybin stopped the neural damage caused by stress, prevented cellular losses, and rebuilt the damaged communication network.

The leader of the research team, Prof. Yi Zuo evaluated, "These data show that psilocybin does not just randomly connect the brain, but directly targets and repairs damaged circuits worn out by stress."

TREATMENT IS POSSIBLE WITHOUT EXPERIENCED WITH "TRIPS" AND HALLUCINATIONS

The biggest debate in the field of psychedelic medicine was whether the severe hallucinations and altered states of consciousness ("trips") created by the drug were essential for treatment. Experts selectively edited serotonin 2A receptors in Layer 5 pyramidal neurons in the cortex using genetic methods.

In critical experiments; It has been proven that the neuroplasticity pathways that reconnect the brain at the cellular level and the behavioral pathways that cause hallucinations work completely independently of each other. In other words, while the healing mechanism of the neurons was activated, the cellular signals that produced hallucinations could be completely turned off.

A SAFER AND ACCESSIBLE NEW ERA IN MENTAL ILLNESS

The discovery will enable the design of a new generation of "non-hallucinogenic" antidepressants that will take away psilocybin's healing power on the brain, while not sending patients into hours-long intense hallucinatory experiences.

Experts state that new neuroplasticity-centered psychiatric treatments, which do not require clinical supervision, do not require hospitalization, and can be safely applied to a much larger population, will reach the clinical stage within a few years.